CKS2 and glioma: Consistently, glioma cells also exhibited enhanced migration capability in wound heal assay when treated with the CKS2 overexpression plasmid compared to the empty vector, while attenuated migration was observed following transfection with CKS2‐siRNA (p < 0.05, Figure 5C–D).